Talk to Alison
00 1 718 618 48 97
Search inside this page
Publication dates
Publishers
All regions
data types
Free Market Research Guides to Download
» Purchase Premium Reports
1-50 of about 1 500 reports
Includes 3 FREE quarterly updates BMI View: We projection deteriorating prospects for drugmakers in Italy because in addition to a decline in public spending on pharmaceuticals (enforced by price cuts ...
Yearly, From 2003 To 2021
By Business Monitor International
Source: Association of the European Self-Medication Industry (AESGP), Pharma.be, BMI
Includes 3 FREE quarterly updates BMI View: Despite numerous challenges, we continue to believe Poland is the most attractive pharmaceutical industry in Central and Eastern Europe (CEE). While the long-awaited ...
Includes 3 FREE quarterly updates BMI View: We stand by our negative projection for the Croatian pharmaceutical industry in 2012, on the back of the weakening economy and wide-ranging cost-containment ...
Includes 3 FREE quarterly updates BMI View: We retain our negative outlook for the pharmaceutical industry in the Czech Republic, expecting a 1.8% contraction in its value in local currency terms in 2012, ...
Includes 3 FREE quarterly updates BMI View: We continue to believe the Belarusian pharmaceutical industry has long-term potential due to the country's favourable geographic position, demographic profile ...
Includes 3 FREE quarterly updates BMI View: While the strength of the UK's pharmaceutical manufacturing market is significant, the segment will face considerable challenges over the coming years. Economic ...
Includes 3 FREE quarterly updates BMI View: Corruption continues to be a major problem within state healthcare services in Serbia. The government are taking measures to tackle the issue but the pharmaceutical ...
BMI View: Moldova's pharmaceutical industry recorded stronger growth in 2011, but its small industry size and its status as the poorest countries in Europe limit its attractiveness as a destination fo ...
Includes 3 FREE quarterly updates BMI View: Belgium, much like most of the other regional industries, is expected to post negative year-onyear (y-o-y) value growth in its 2012 pharmaceutical revenues because ...
BMI View: Despite the threat of austerity measures and the government's focus on cost-containment within the pharmaceuticals and healthcare segment, as well as the impact of generic competition as a result ...
Includes 3 FREE quarterly updates BMI View: The challenges facing drugmakers in Greece in 2012 will be considerably tougher than those faced in 2011. With the introduction of new cost-containment legislation ...
BMI View: While we continue to see huge potential in the Ukrainian pharmaceutical industry, we are pessimistic with regard to short- and medium-term stability in the industry place. In particular, we ...
Includes 3 FREE quarterly updates BMI View: While Finland's pharmaceutical market is small compared with its Western European neighbours, BMI believes the country's high public expenditure on health and ...
Includes 3 FREE quarterly updates Core Views The Dutch economy's growth outlook is set to seriously deteriorate in the coming quarters, as the eurozone sovereign debt crisis massively weighs on economic ...
BMI View: Slovenia's pharmaceutical industry outlook remains broadly unchanged in our Q212 assessment. While weak economic data and revised projections have led us to adjust our drug industry projections ...
BMI View: Sweden's high public expenditure on health (SEK252bn, or US Dollar 39bn, in 2011), accounting for 79% of total healthcare expenditure) is a major factor in making it an attractive place to sell ...
BMI View: Some changes have been made to the original March 2011 proposal to reduce costs in the pharmaceutical industry, representing moderately good news for drugmakers. However, this development will ...
BMI View: While the Netherlands is a low risk industry from the point of view of multinational drugmakers, the country's modest per capita expenditure on pharmaceuticals relative to other Western Europe ...
BMI View: Despite a contraction in pharmaceutical prices, Latvia's pharmaceutical industry performed strongly in first nine months of 2011, which has led to upward revisions to our outlook for 2011 and ...
BMI View: The pharmaceuticals and healthcare segment will be a target of further cost containment, particularly as National Health System (SSN) data for H111, which shows a decline in spending, highlights ...
BMI View: Following the resignation of Emil Boc and his government in February 2012, there is now considerable uncertainty with regard to reform of the Romanian healthcare segment . In particular, draft ...
BMI View: Since the approval of an EU/ECB/IMF economic rescue package in May 2011, cost cutting measures have taken their toll on all segments - including the pharmaceutical and healthcare market . Following ...
BMI View: We believe the Spanish government's austerity measures are a necessary and prudent course of action. The country still has the third highest budget deficit in the eurozone and continues to receive ...
Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN SERBIA While the market is small in terms of absolute numbers, relative per capita ...
Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN UKRAINE Foreign and domestic drugmakers in Ukraine will see their operating margins ...
Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN THE NETHERLANDS While the Netherlands is a low-risk market from the point of view ...
Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN SLOVAKIA Slovak Prime Minister Robert Fico plans to unify the country'sprivate and ...
Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN UNITED KINGDOM Drugmakers and governments will increasingly enter agreements that ...
Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN CROATIA The Croatian pharmaceutical market continues to pose a challenging environment ...
Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN ITALY The sharp drop in public pharmaceutical expenditure in Italy in the first fou ...
» Download Public Reports
About 1 000 reports
... Hhs), has awarded the company a contract valued at up to usd 228 million for the continued supply of the company S imvamune smallpox vaccine. The first usd 110 million of the new order is secured ...
» Read our Company Profiles
2 CompaniesReportlinker.com © Copyright 2013. All rights reserved.